Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers By Ogkologos - April 9, 2026 227 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the real-world study conducted by the Netherlands Cancer Institute Source RELATED ARTICLESMORE FROM AUTHOR Combining 177Lu-PSMA-617 with ADT Plus ARPI Prolongs rPFS in Patients with PSMA-positive Metastatic Androgen Pathway Modulator-Naive/Sensitive Prostate Cancer EMA Recommends Extension of Therapeutic Indications for Cetuximab No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy with Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma MOST POPULAR In Memory of Håkan Mellstedt: Former ESMO President August 26, 2025 FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab... August 5, 2026 Brentuximab May Mean Less Radiation for Children, Teens with Hodgkin Lymphoma May 7, 2021 pCR Correlates with RFS and OS with Neoadjuvant Therapy in Stage... February 16, 2021 Load more HOT NEWS Licorice: The Unique Root With 10 Amazing Health Benefits What Cancer Caregivers Should Know About Hospice Care at Home: A... FDA Approves Avapritinib for Advanced Systemic Mastocytosis FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC...
